<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Head Face Med</journal-id>
      <journal-title>Head &amp; Face Medicine</journal-title>
      <issn pub-type="epub">1746-160X</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">16412234</article-id>
      <article-id pub-id-type="pmc">1368969</article-id>
      <article-id pub-id-type="publisher-id">1746-160X-2-1</article-id>
      <article-id pub-id-type="doi">10.1186/1746-160X-2-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Fanconi anemia manifesting as a squamous cell carcinoma of the hard palate: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" equal-contrib="yes" corresp="yes" contrib-type="author">
          <name>
            <surname>Gasparini</surname>
            <given-names>Giulio</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>giuliogasparini@yahoo.it</email>
        </contrib>
        <contrib id="A2" equal-contrib="yes" contrib-type="author">
          <name>
            <surname>Longobardi</surname>
            <given-names>Gianluigi</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>gianluigilongobardi@libero.it</email>
        </contrib>
        <contrib id="A3" equal-contrib="yes" contrib-type="author">
          <name>
            <surname>Boniello</surname>
            <given-names>Roberto</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>drboniello@yahoo.it</email>
        </contrib>
        <contrib id="A4" equal-contrib="yes" contrib-type="author">
          <name>
            <surname>Di Petrillo</surname>
            <given-names>Alessandro</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>alessandrodp9@hotmail.com</email>
        </contrib>
        <contrib id="A5" equal-contrib="yes" contrib-type="author">
          <name>
            <surname>Pelo</surname>
            <given-names>Sandro</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>sandro.pelo@rm.unicatt.it</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>U.O. Maxillofacial Surgery. Catholic University Medical School, Rome, Italy</aff>
      <pub-date pub-type="collection">
        <year>2006</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>1</month>
        <year>2006</year>
      </pub-date>
      <volume>2</volume>
      <fpage>1</fpage>
      <lpage>1</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.head-face-med.com/content/2/1/1"/>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>10</month>
          <year>2005</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>1</month>
          <year>2006</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2006 Gasparini et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2006</copyright-year>
        <copyright-holder>Gasparini et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
          <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Gasparini
               Giulio
               
               giuliogasparini@yahoo.it
            </dc:author><dc:title>
            Fanconi anemia manifesting as a squamous cell carcinoma of the hard palate: a case report
         </dc:title><dc:date>2006</dc:date><dcterms:bibliographicCitation>Head &#x00026; Face Medicine 2(1): 1-. (2006)</dcterms:bibliographicCitation><dc:identifier type="sici">1746-160X(2006)2:1&#x0003c;1&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1746-160X</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
        </license>
      </permissions>
      <abstract>
        <p>Fanconi Anemia is a rare autosomal recessive disorder characterized by various congenital malformations, progressive bone marrow failure at a very young age and of solid tumors development. The authors present a rare case of a squamous cell carcinoma of the hard palate in a Fanconi Anaemia patient. The atypical clinical manifestation rendered the diagnosis more difficult. This case, for age of appearance, sex and localization, is unique in international literature. We recommend a quarterly follow up of the oral-rhino-pharynx complex in FA patients and to consider as carcinomas, all oral lesions that last more than two weeks.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Fanconi Anemia (FA) is a rare autosomal recessive syndrome (birth incidence of 1 per 350000), first described in 1927 as a progressive lethal anaemia associated with brown pigmentation of skin [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Subsequently, this term was extended to a syndrome that includes pancytopenia with hypoplastic bone marrow, skeletal, renal and ophtalmological malformations and chromosomal aberrations. The disease involves many organs including skin and genitourinary, musculoskeletal, cardiovascular and neurological systems. The clinical findings in FA patients are hyperpigmentation, small reproductive organs in males, kidney problems, thumbs and arm abnormalities, skeletal anomalies of hip, spine or ribs, low birth weight, short stature, growth retardation, defects of the tissue separating the heart chambers and mental retardation or learning disabilitym [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. Most cases of FA manifest anaemia symptoms during childhood. However, the symptoms may not become apparent until adulthood [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. FA patients are at risk for secondary malignancies, for example leukaemia, squamous cell carcinoma and hepatocellular carcinoma [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B9">9</xref>]. The risk of squamous cell carcinoma development is expecially high in the anogenital region as well as the head and neck region [<xref ref-type="bibr" rid="B10">10</xref>] Increased susceptibility of the oral cavity and anogenital region to local predisposing factors, including environmental toxins and viruses [<xref ref-type="bibr" rid="B5">5</xref>]. The authors report a new case of hard palate squamous cell carcinoma in a FA patient. The clinical history and localization of the tumour make this case unique.</p>
    </sec>
    <sec>
      <title>Case report</title>
      <p>The patient, a 27-year-old white male, was referred by a private oral surgeon to our hospital for evaluation of a hard palate lesion that had appeared six months before (Figure <xref ref-type="fig" rid="F1">1</xref>). The lesion had been diagnosed initialing as gingivitis by the private oral surgeon and treated with local topical medicines without any remission.</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>Preoperative hard and soft palate lesion.</p>
        </caption>
        <graphic xlink:href="1746-160X-2-1-1"/>
      </fig>
      <p>At the age of seven the patient was recovered for an orthopaedic trauma. He had been diagnosed with FA at the age of seven after that pancytopenia was noticed during routine blood examinations for orthodontic trauma. He had been treated with androgenic therapy and had not received a bone marrow transplant. The haematological test revealed an early stage of pancytopenia (3,4 &#xD7; 109/l, Hb 12,3 g/dl, and platelets 13 &#xD7; 10<sup>9</sup>/l).</p>
      <p>Oral examination revealed a relatively well-defined, nearly circular, concave ulcer measuring 3 &#xD7; 4 cm, which extended from the hard palatal mucosa in the upper molar region to the adjacent soft palatal mucosa. The surface was erythematous and smooth, with some telangiectasias. Clinical examination showed no regional lymphadenopathy. CT and MR imaging showed a hard and soft tissue mass extending from molar region mucosa to the soft palate mucosa. The nasopharynx appeared normal (Figure <xref ref-type="fig" rid="F2">2</xref>). No significant cervical lymphadenopathy was seen on the images. An incisional biopsy performed under local anaesthesia revealed a well-differentiated squamous cell carcinoma (Figure <xref ref-type="fig" rid="F3">3</xref>).</p>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p>Preoperative CT image.</p>
        </caption>
        <graphic xlink:href="1746-160X-2-1-2"/>
      </fig>
      <fig position="float" id="F3">
        <label>Figure 3</label>
        <caption>
          <p>Biopsy finding: Well-differentiated squamous cell carcinoma.</p>
        </caption>
        <graphic xlink:href="1746-160X-2-1-3"/>
      </fig>
      <p>The tumor was surgically removed with a right partial maxillectomy extendiney to homolateral soft mucosa and clear magins. Reconstruction was accomplished with a temporalis muscle flap. The patient has been followed up for 6 months without any evidence of recurrence or metastasis.</p>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Fanconi Anemia is a rare autosomal recessive disorder characterized by various congenital malformations, progressive bone marrow failure at a very young age and of solid tumors development. FA is defined by its cellular hypersensitivity to DNA cross-linking agent such as diepoxybutane (DEB) and mitomycin (MML). Presence of mutations of in one of the different FA genes, FA can be divided into eight complementary groups (A, B, C, D1, D2, E, F, G), with each group having in common the cellular hypersensitivity to cross-linking agent. In the International Fanconi Anemia Registry (IFAR) complementation group A (65%), C (15%) and G (10%) are the most common [<xref ref-type="bibr" rid="B11">11</xref>].</p>
      <p>The severity is determined by specific complementation group and over all by the type of genetic mutation. Because of these phenotypic differences among complementation groups, FA is a heterogeneous disease. If impaired genetic factors cause an early appearance of the FA syndrome, the same factors may cause an early appearance of malignancies. Thus, there are two distinct groups of patients: (1) severe genetic disturbance with early FA symptoms and early malignancies; (2) mild disturbances with delayed FA symptoms and late malignancies [<xref ref-type="bibr" rid="B2">2</xref>]. Kaplan suggested that there are two defects determining the development of cancer in FA patients: defective chromosomal stability and immunodeficiency [<xref ref-type="bibr" rid="B12">12</xref>].</p>
      <p>Patients that have endured bone marrow transplantation have a greater incidence of malignancies development. In these patients, there are four additional factors including pretransplant total body irradiation, cyclophosphamide treatment, chronic graft versus host disease, and prolonged immunosuppressive treatment after transplantation [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>].</p>
      <p>The highest incidence of cancer development in FA patients is reported by Kuttler [<xref ref-type="bibr" rid="B11">11</xref>]. In this study he compared the incidence of Hard Neck Squamous Cell Carcinoma (HNSCC) in common population (0.038%) and in FA patients (3%). The first to describe a HNSCC in a FA patient were Esparza and Thompson [<xref ref-type="bibr" rid="B4">4</xref>]. Jansisyanont reported that the commonest localizations of squamous cell carcinoma in FA patients in descending order are: tongue, anogenital region, pharynx, larynx, oral mucosa, mandible and skin [<xref ref-type="bibr" rid="B13">13</xref>].</p>
      <p>Lustig published a review of the international bibliography on the HNSCC in FA patients [<xref ref-type="bibr" rid="B2">2</xref>]. He presented 17 cases. In 13 patients the cancer localization was intra-oral. In 9 cases of these 13, the tongue was involved. According with this, in FA patients the tongue cancer incidence is 69%, while in non FA patients the incidence varies by 10 to 16% [<xref ref-type="bibr" rid="B2">2</xref>].</p>
      <p>Kuttler in 2003 referred that 19 of 754 patients in the International Fanconi Anaemia Registry (3%) had HNSCC [<xref ref-type="bibr" rid="B11">11</xref>]. In the same year Bremer presented two cases of HNSCC [<xref ref-type="bibr" rid="B15">15</xref>], but in international literature no article has reported a hard palate localization of HNSCC.</p>
      <p>The male:female ratio of HNSCC in normal population is 2:1 while Reed asserted the reversed ratio in FA patients [<xref ref-type="bibr" rid="B16">16</xref>]. FA patients develop squamous cell carcinoma at significantly earlier age than the general population. Kenedy and Hart reported an average age of 27 years in FA patients [<xref ref-type="bibr" rid="B17">17</xref>] and the average time between age of FA diagnosis and cancer development is 10.5 years [<xref ref-type="bibr" rid="B2">2</xref>].</p>
      <p>The treatment of malignancies in FA patients with HNSCC is similar to the general population with similar pathologies. The aim is the tumour resection oncologic radicality. The main preoperative problem in patients with FA is the associated bone marrow failure, requiring preoperative haematologic consultations. The possibility of blood and platelet transfusion before surgery must be considered. We think that the first approach in FA patients is surgical resection of primary HNSCC with, if necessary, neck dissection and reconstruction. Generally, FA patients withstand surgical procedures very well. A further concern for the surgeon is the development of postoperative complications, including wound infections and haematoma. Although our patient did not develop postoperative complications, FA patients can have serious problems in adjuvant therapy due to increased susceptibility to mutagenic stimuli [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B13">13</xref>].</p>
      <p>In FA patients, radiotherapy and chemotherapy follow different therapeutic principles. In FA patients the increased susceptibility to XRT and CTx can present problems to determine and to deliver a cancericidal dose without causing significant damage to normal tissue. Thus, in these patients standard doses for adjuvant therapy are generally reduced. Furthermore, the use of conventional protocols, which include cross-linking agents, can cause severe systemic complications, including irreversible aplastic anaemia and catastrophic organ damage [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B18">18</xref>].</p>
      <p>Because SCC in FA is difficult to treat once advanced, it is necessary to diagnose malignancies at early stage. We agree with the protocol proposed by Kutler [<xref ref-type="bibr" rid="B11">11</xref>]. He suggests a careful biannual screening of the oral cavity and oropharynx that should start between the ages of 15 and 20. However, in patients with FA with histrory of leucoplakia or recurrent oral lesions, head and neck examinations are recommended every six or eight weeks.</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>We report a unique localization of hard and soft squamous cell carcinoma in a FA patient. The atypical clinical manifestation rendered the diagnosis more difficult. We recommend a quarterly follow up of the oral-rhino-pharynx complex in FA patients and to consider as carcinomas, all oral lesions that last more than two weeks.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The author(s) declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>GG drafted the manuscript. GL, RB and ADP carried out the literature search. All authors participated in the treatment of the patient. All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>We are very grateful to Prof. Vivek Shetty (UCLA School of Dentistry, Los Angeles, CA, USA) for his efforts and support in the final preparation of this manuscript for Head &amp; Face Medicine.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fanconi</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Familiare infantile perniziosaartige An&#xE4;mie (pernizi&#xF6;ses Blutbild und Konstitution)</article-title>
          <source>Jahrbuch f&#xFC;r Kinderheilkunde und physische Erziehung</source>
          <year>1927</year>
          <volume>117</volume>
          <fpage>257</fpage>
          <lpage>280</lpage>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lustig</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Lugassy</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Neder</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sigler</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Head and neck carcinoma in Fanconi's anaemia-report of a case and review of the literature</article-title>
          <source>Eur J Cancer B Oral Oncol</source>
          <year>1995</year>
          <volume>31</volume>
          <fpage>68</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="pmid">7627092</pub-id>
          <pub-id pub-id-type="doi">10.1016/0964-1955(94)00044-5</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Swift</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Hirschhorn</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Fanconi's anemia. inherited susceptibility to chromosome breakage in various tissue</article-title>
          <source>Ann Intern Med</source>
          <year>1966</year>
          <volume>65</volume>
          <fpage>496</fpage>
          <lpage>503</lpage>
          <pub-id pub-id-type="pmid">5911745</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Esparza</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>WK</given-names>
            </name>
          </person-group>
          <article-title>Familial hypoplastic anemia with multiple congenital anomalies (Fanconi's syndrome) &#x2013; report of three cases. Cases presented are of two sisters and a female cousin with complete clinical and post mortem findings</article-title>
          <source>R I Med J</source>
          <year>1966</year>
          <volume>49</volume>
          <fpage>103</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">5217141</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Joenje</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Matthew</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gluckman</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Fanconi anaemia research: current status and prospects</article-title>
          <source>Eur J Cancer</source>
          <year>1995</year>
          <volume>31</volume>
          <fpage>268</fpage>
          <lpage>272</lpage>
          <pub-id pub-id-type="pmid">7718336</pub-id>
          <pub-id pub-id-type="doi">10.1016/0959-8049(94)00485-N</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>dos Santos</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Gavish</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Buchwald</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Fanconi anemia revisited: old ideas and new advances</article-title>
          <source>Stem Cells</source>
          <year>1994</year>
          <volume>12</volume>
          <fpage>142</fpage>
          <lpage>153</lpage>
          <pub-id pub-id-type="pmid">8199559</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Linares</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pastor</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gomez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Grau</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Hepatocellular carcinoma and squamous cell carcinoma in a patient with Fanconi's anemia</article-title>
          <source>Ann Hematol</source>
          <year>1991</year>
          <volume>63</volume>
          <fpage>54</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="pmid">1652289</pub-id>
          <pub-id pub-id-type="doi">10.1007/BF01714963</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>LeBrun</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Silver</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Freedman</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Fibrolamellar carcinoma of the liver in a patient with Fanconi anemia</article-title>
          <source>Hum Pathol</source>
          <year>1991</year>
          <volume>22</volume>
          <fpage>396</fpage>
          <lpage>398</lpage>
          <pub-id pub-id-type="pmid">1646763</pub-id>
          <pub-id pub-id-type="doi">10.1016/0046-8177(91)90088-7</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moldvay</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schaff</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Lapis</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Hepatocellular carcinoma in Fanconi's anemia treated with androgen and corticosteroid</article-title>
          <source>Zentralbl Pathol</source>
          <year>1991</year>
          <volume>137</volume>
          <fpage>167</fpage>
          <lpage>170</lpage>
          <pub-id pub-id-type="pmid">1655018</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oksuzoglu</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Yalcin</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Squamous cell carcinoma of the tongue in a patient with Fanconi's anemia: a case report and review of the literature</article-title>
          <source>Ann Hematol</source>
          <year>2002</year>
          <volume>81</volume>
          <fpage>294</fpage>
          <lpage>298</lpage>
          <pub-id pub-id-type="pmid">12029542</pub-id>
          <pub-id pub-id-type="doi">10.1007/s00277-002-0455-6</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kutler</surname>
              <given-names>DI</given-names>
            </name>
            <name>
              <surname>Auerbach</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Satagopan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Giampietro</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Batish</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Huvos</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Goberdhan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia</article-title>
          <source>Arch Otolaryngol Head Neck Surg</source>
          <year>2003</year>
          <volume>129</volume>
          <fpage>106</fpage>
          <lpage>112</lpage>
          <pub-id pub-id-type="pmid">12525204</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaplan</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Sabio</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wanebo</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Cantrell</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Squamous cell carcinoma in the immunosuppressed patient: Fanconi's anemia</article-title>
          <source>Laryngoscope</source>
          <year>1985</year>
          <volume>95</volume>
          <fpage>771</fpage>
          <lpage>775</lpage>
          <pub-id pub-id-type="pmid">4010414</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jansisyanont</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pazoki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ord</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Squamous cell carcinoma of the tongue after bone marrow transplantation in a patient with Fanconi's anemia</article-title>
          <source>J Oral Maxillofac Surg</source>
          <year>2000</year>
          <volume>58</volume>
          <fpage>1454</fpage>
          <lpage>1457</lpage>
          <pub-id pub-id-type="pmid">11117702</pub-id>
          <pub-id pub-id-type="doi">10.1053/joms.2000.19212</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Socie</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Scieux</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gluckman</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Soussi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Clavel</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Saulnier</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Birembault</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bosq</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Morinet</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Janin</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Squamous cell carcinomas after allogeneic bone marrow transplantation for aplastic anemia: further evidence of a multistep process</article-title>
          <source>Transplantation</source>
          <year>1998</year>
          <volume>66</volume>
          <fpage>667</fpage>
          <lpage>670</lpage>
          <pub-id pub-id-type="pmid">9753353</pub-id>
          <pub-id pub-id-type="doi">10.1097/00007890-199809150-00023</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bremer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schindler</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gross</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dork</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Morlot</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Karstens</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Fanconi's anemia and clinical radiosensitivity report on two adult patients with locally advanced solid tumors treated by radiotherapy</article-title>
          <source>Strahlenther Onkol</source>
          <year>2003</year>
          <volume>179</volume>
          <fpage>748</fpage>
          <lpage>753</lpage>
          <pub-id pub-id-type="pmid">14605744</pub-id>
          <pub-id pub-id-type="doi">10.1007/s00066-003-1099-8</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reed</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ravikumar</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Gifford</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Grage</surname>
              <given-names>TB</given-names>
            </name>
          </person-group>
          <article-title>The association of Fanconi's anemia and squamous cell carcinoma</article-title>
          <source>Cancer</source>
          <year>1983</year>
          <volume>52</volume>
          <fpage>926</fpage>
          <lpage>928</lpage>
          <pub-id pub-id-type="pmid">6347359</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kennedy</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Hart</surname>
              <given-names>WR</given-names>
            </name>
          </person-group>
          <article-title>Multiple squamous-cell carcinomas in Fanconi's anemia</article-title>
          <source>Cancer</source>
          <year>1982</year>
          <volume>50</volume>
          <fpage>811</fpage>
          <lpage>814</lpage>
          <pub-id pub-id-type="pmid">7093916</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alter</surname>
              <given-names>BP</given-names>
            </name>
          </person-group>
          <article-title>Radiosensitivity in Fanconi's anemia patients</article-title>
          <source>Radiother Oncol</source>
          <year>2002</year>
          <volume>62</volume>
          <fpage>345</fpage>
          <lpage>347</lpage>
          <pub-id pub-id-type="pmid">12175566</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0167-8140(01)00474-1</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
